Home/Filings/4/0001209191-21-025713
4//SEC Filing

Hammill Kevin Austin 4

Accession 0001209191-21-025713

CIK 0001441693other

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 5:41 PM ET

Size

5.1 KB

Accession

0001209191-21-025713

Insider Transaction Report

Form 4
Period: 2021-04-02
Hammill Kevin Austin
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2021-04-02+38,94277,315 total
Footnotes (2)
  • [F1]The common stock is acquired by issuance of restricted stock units that vest and settle on May 20, 2021.
  • [F2]The number of securities reported also reflects the acquisition of a total of 38,373 shares of the issuer's common stock pursuant to the issuer's employee stock purchase plan.

Issuer

MARRONE BIO INNOVATIONS INC

CIK 0001441693

Entity typeother

Related Parties

1
  • filerCIK 0001739741

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 5:41 PM ET
Size
5.1 KB